Fukushima Yuki

フクシマユウキ | Fukushima Yuki

Affiliation and department：
Job title：特任助教

Research field (1)： Radiology

Research keywords (3)： DNA損傷修復 , 放射線腫瘍学 , 腫瘍免疫と放射線治療

Research theme for competitive and other funds (4)：

2021 - 2024 頭頸部癌における腫瘍免疫の微小環境の解析と個別化放射線治療への応用
2019 - 2021 Analysis of tumor immunity and radiation therapy for head and neck cancer by immunostaining and liquid biopsy
2018 - 2021 Development of a practical radiosensitivity prediction method for clinical applications
2015 - 2018 Development of methods predicting radiosensitivity that can be clinically applied

Papers (25)：

Tomokazu Hasegawa, Masanori Someya, Takaaki Tsuchiya, Mio Kitagawa, Yuki Fukushima, Toshio Gocho, Shoh Mafune, Ryuu Okuda, Juno Kaguchi, Atsuya Ohguro, et al. Identification and Quantification of Radiotherapy-related Protein Expression in Cancer Tissues Using the Qupath Software and Prediction of Treatment Response. In vivo (Athens, Greece). 2024. 38. 3. 1470-1476
Someya Masanori, Hasegawa Tomokazu, Kitagawa Mio, Tsuchiya Takaaki, Fukushima Yuki, Gocho Toshio, Mafune Shou, Kanaseki Takayuki, Tokita Serina, Sakata Koh-ichi. 末梢血リンパ球TCRレパトア解析を用いたNSCLCの治療効果予測(Prediction of Treatment Response in NSCLC using Peripheral Blood Lymphocyte TCR Repertoire Analysis). 日本医学放射線学会学術集会抄録集. 2023. 82回. S173-S173
Masanori Someya, Serina Tokita, Takayuki Kanaseki, Mio Kitagawa, Tomokazu Hasegawa, Takaaki Tsuchiya, Yuki Fukushima, Toshio Gocho, Yoh Kozuka, Shoh Mafune, et al. Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer. Cancer science. 2022. 113. 12. 4394-4400
Masanori Someya, Tomokazu Hasegawa, Takaaki Tsuchiya, Mio Kitagawa, Yuki Fukushima, Toshio Gocho, Shoh Mafune, Yutaro Ikeuchi, Yoh Kozuka, Masashi Idogawa, et al. Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy. Medical molecular morphology. 2022. 56. 1. 38-45
染谷正則, 土屋高旭, 福島悠希, 長谷川智一, 井戸川雅史, 松浦基樹, 岩崎雅宏, 廣橋良彦, 鳥越俊彦, 齋藤豪, et al. 血中エクソソーム由来miRNAを用いた子宮頸癌の治療効果予測. 日本癌治療学会学術集会抄録集. 2022. 60回. P102-2

ｍore...

MISC (18)：

染谷正則, 土屋高旭, 福島悠希, 池内佑太郎, 眞船翔, 小塚陽, 北川未央, 後町俊夫, 坂田耕一. 血中エクソソームmiRNAを用いた子宮頸癌の治療効果予測. 日本免疫治療学会学術集会プログラム・抄録集. 2022. 19th
染谷正則, 土屋高旭, 福島悠希, 長谷川智一, 井戸川雅史, 松浦基樹, 岩崎雅宏, 廣橋良彦, 鳥越俊彦, 齋藤豪, et al. 血中エクソソーム由来miRNAを用いた子宮頸癌の治療効果予測. 日本癌治療学会学術集会(Web). 2022. 60th
染谷正則, 土屋高旭, 福島悠希, 廣橋良彦, 鳥越俊彦, 坂田耕一. 免疫放射線療法 HPV関連癌における癌免疫と放射線療法効果の関係性(Relationship between tumor immunity and radiotherapy effects in HPV associated cancer). 日本医学放射線学会秋季臨床大会抄録集. 2020. 56回. S34-S34
染谷正則, 土屋高旭, 福島悠希, 長谷川智一, 高田優, 中田健生, 堀正和, 三浦勝利, 北川未央, 後町俊夫, et al. 根治放射線療を行った進行期子宮頸癌症例における腫瘍免疫と予後の関連. 日本癌治療学会学術集会抄録集. 2020. 58回. O16-4
松本健一, 福島悠希, 後町俊夫, 土屋高旭, 北川未央, 堀正和, 中田健生, 染谷正則, 坂田耕一, 高田優, et al. 当院での子宮頸癌の根治的放射線治療成績 192-Ir HDR RALS導入後6年での解析. Japanese Journal of Radiology. 2018. 36. Suppl. 6-6

ｍore...

Professional career (1)：

医学博士 (札幌医科大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page